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Combinatorial Roles of Heparan Sulfate Proteoglycans
and Heparan Sulfates in Caenorhabditis elegans Neural
Development
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Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom, and Department of Biology, University of Huddersfield, Huddersfield, United Kingdom
Abstract
Heparan sulfate proteoglycans (HSPGs) play critical roles in the development and adult physiology of all metazoan
organisms. Most of the known molecular interactions of HSPGs are attributed to the structurally highly complex heparan
sulfate (HS) glycans. However, whether a specific HSPG (such as syndecan) contains HS modifications that differ from
another HSPG (such as glypican) has remained largely unresolved. Here, a neural model in C. elegans is used to demonstrate
for the first time the relationship between specific HSPGs and HS modifications in a defined biological process in vivo.
HSPGs are critical for the migration of hermaphrodite specific neurons (HSNs) as genetic elimination of multiple HSPGs leads
to 80% defect of HSN migration. The effects of genetic elimination of HSPGs are additive, suggesting that multiple HSPGs,
present in the migrating neuron and in the matrix, act in parallel to support neuron migration. Genetic analyses suggest
that syndecan/sdn-1 and HS 6-O-sulfotransferase, hst-6, function in a linear signaling pathway and glypican/lon-2 and HS 2-O-
sulfotransferase, hst-2, function together in a pathway that is parallel to sdn-1 and hst-6. These results suggest core protein
specific HS modifications that are critical for HSN migration. In C. elegans, the core protein specificity of distinct HS
modifications may be in part regulated at the level of tissue specific expression of genes encoding for HSPGs and HS
modifying enzymes. Genetic analysis reveals that there is a delicate balance of HS modifications and eliminating one HS
modifying enzyme in a compromised genetic background leads to significant changes in the overall phenotype. These
findings are of importance with the view of HS as a critical regulator of cell signaling in normal development and disease.
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Introduction
Heparan sulfate (HS) and HS proteoglycans (HSPGs) critically
regulate a range of biological processes in metazoan organisms
from early events in gastrulation to adult physiology, disease and
host response to pathogens (for reviews see [1,2,3]. The
involvement of HS/HSPGs in such a broad range of biological
activities is due to their ability to interact with a vast repertoire of
proteins such as growth factors, morphogens, enzymes, extracel-
lular matrix and plasma proteins. The molecular interactions of
HSPGs occur predominantly via the negatively charged HS
glycans attached to the proteoglycan protein core. The biosyn-
thesis of HS occurs in the Golgi complex, where a set of
polymerases first synthesize the polysaccharide backbone consist-
ing of N-acetylglucosamine (GlcNAc) and glucuronic acid (GluA)
residues. The linear HS backbone undergoes a complex pattern of
modifications at selective positions. The first modification step is
N-deacetylation and subsequent N-sulfation of some glucosamine
units. Subsequent epimerization of some GluA units to iduronic
acid (IdoA) and sulfation at C2 hydroxyl group of GluA/IdoA and
sulfation at C6 or C3 of the glucosamine are actions of a
glucuronyl C5-epimerase and heparan 2-, 6- and 3-O-sulfotrans-
ferases, respectively. These modifications generally occur in the N-
sulfated regions creating domains of high sulfate density (NS-
domains), intermediate sulfate density (NS/NA-domains) and low
sulfate density (NA-domains). HS biosynthesis is not template-
driven and enzymatic reactions do not modify every sugar unit,
resulting in huge structural complexity in one of the most
heterogeneous molecules in biology.
In vertebrates, most of the HS biosynthetic enzymes are
encoded by members of multigene families. Multiple isoenzymes
for HS polymerases (EXT/EXTL) [4,5,6], four N-deacetylase/N-
sulfotransferases (NDSTs; [7], three glucosaminyl 6-O-sulfotrans-
ferases (HS6STs; [8] and seven isoforms of glucosaminyl 3-O-
sulfotransferases (HS3STs; [9] have been identified to date. The
specific isoenzymes possess differential substrate specificities. Only
a single glucuronyl C5-epimerase [10] and uronyl 2-O-sulfotrans-
ferase (HS2ST; [11] have been identified to date.
Biochemical analyses have revealed developmental and disease
related changes to HS composition. Gene knock-out studies have
identified key signaling pathways and developmental processes
that require the activities of specific HS biosynthetic enzymes. For
example, genetic elimination of mouse Hs2st leads to complete
lack of kidneys and neonatal lethality [11]. Targeted disruption of
C5-epimerase in mice leads to renal agensis, lung defects and
skeletal malformation [12]. Targeted disruption of HS biosynthet-
ic enzymes is expected to affect all different HSPGs expressed in
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the targeted tissue or developmental stage. Similarly, most
biochemical analyses to structural changes in HS have used whole
animal or tissue samples containing a pool of HSPGs. There is
limited data on the relationship between HS structures and specific
core proteins and whether the core protein influences structural
specificity of the HS. Mouse syndecan and glypican HSPGs
ectopically expressed in immortalized cell lines are decorated with
HS of similar structural composition [13] suggesting that at least
in vitro, the core protein context is not critical for HS structure
determination. Syndecan and glypican from rat embryonic
fibroblasts carry HS chains of different molecular mass, but
similar charge and structural composition, yet display differential
binding to fibronectin, suggesting that the core protein may
determine ligand specificity [14]. However, syndecan-3 purified
from perinatal rat forebrain is decorated with HS that contains a
higher degree of N-sulfation and IdoA units as compared to
average tissue HS [15] suggesting that the structural regulation of
specific HS is more complex in vivo.
The C. elegans hermaphrodite specific neurons (HSNs) are a
pair of serotonergic neurons that innervate the vulval muscles and
are necessary and sufficient to initiate egg laying [16]. The HSNs
are born in the tail of the embryo and during embryonic
development the HSNs migrate to mid body, to the immediate
proximity of the developing vulva. Defects in HSN development
often result in egg-laying defects, which can be readily observed as
accumulation of embryos inside the mother.
This study sought to address the relation between a specific
HSPG core protein and distinct HS motifs using a neural
development model in C. elegans in vivo. C. elegans has in most
cases a single orthologue of vertebrate genes encoding for HSPG
core proteins and HS biosynthetic enzymes facilitating analysis
without genetic redundancy [17,18,19,20,21,22,23,24]. Develop-
mental genetic approach was used to assess the relation between
specific HS structures on different HSPG core proteins for the
migration of the HSNs. The HSNs undergo a significant
developmental migration in relation to the C. elegans body plan,
and were thus chosen as a model to assess HSPGs and HS in
neural development. Multiple HSPG dependent neuron guidance
pathways are required for HSN migration in parallel. These
parallel pathways rely on different HS modifications. Genetic
analysis also suggests an interdependence of HS biosynthetic
enzymes during HS biosynthesis.
Materials and Methods
Strains- C. elegans strains were maintained at 20uC essentially
as described [25] unless otherwise stated. Wild type strain used in
this study is N2 var. Bristol. The following previously described
mutations were used: LGI: cle-1 (cg120) [22]; LGIII: hse-5
(tm472) [21], rib-2 (tm710) [23]; LGIV: rib-1 (ok556) [24], hst-1
(ok1068); LGX: lon-2 (e678) [18], hst-6 (ok273) [17], sdn-
1(zh20) [26], sdn-1(ok449) [20], hst-2(ok595) [19,21,26], gpn-1
(ok377) [27]. tm734 and tm3006 are deletion alleles of hst-3.1 and
hst-3.2, respectively, generated by Shohei Mitani and the Japanese
National Bioresource Project. tm734 is a 448 bp deletion and 4 bp
insertion eliminating exons 2 and 3 and parts of exon 4 and
tm3006 is a 230 bp deletion removing parts of exons two and
three. Both mutant alleles were backcrossed at least three times
prior to analysis. Both mutants are homozygous viable and fertile
and display no overt phenotypic defects as single mutants. The
following transgenes were used; zdIs13 [Ptph-1::GFP] [28],
mgIs71 [Ptph-1::GFP;rol-6(d)] [29]. Double and triple mutants
were generated using standard genetic methods.
Reporter constructs
Standard molecular biological techniques were used. The sdn-
1::gfp transcriptional reporter contains 1.5 kb of sequence
upstream from predicted ATG site cloned into SphI/SmaI sites
of pPD95.75. The hst-3.1::gfp and hst-3.2::gfp reporters contain a
2 kb of sequence upstream from corresponding predicted ATG
site cloned into SphI/XbaI and SphI/BamHI restriction sites of
pPD95.75, respectively. DNA constructs were injected at 30 mg/
ml. pttx-3::mCherry or ptph-1::mCherry were used as injection
markers at 50 mg/ml and pBluescript was used as a filler DNA.
Neuron scoring
HSN neuron migration was scored using cell specific fluorescent
reporters that are expressed in the HSNs. Each C. elegans has two
HSNs but sometimes it was not possible to see both HSNs due to
the position of the animal. Neuron scores are thus presented as
number of total neurons scored, rather than number of animals
scored, unless otherwise stated. Statistical significance was tested
using either Student’s t-test or Fisher’s test.
Microscopy
Microscopy of living C. elegans was performed by mounting the
animals on a 4% agarose pad in a drop of M9 buffer containing
30 mM NaN3 as an anesthetic. HSN migration was scored under
fluorescent microscopy using GFP expression in all serotonergic
neurons including the HSNs. Compound fluorescent images were
acquired using Zeiss AxioCam MRm camera mounted on Zeiss
Axioskop2 microscope equipped with x20, x40 and x63 optics.
Images were captured using Axiovision. Confocal images were
acquired using Leica AOBS SP2 system and images were captured
using Leica software. Microscopy images were further cropped
and scaled using Adobe Photoshop CS3 (Adobe Systems, San Jose,
CA).
Results
Parallel HSPG dependent pathways are required for HSN
migration
Unlike mammals which have four syndecan and six glypican
genes, the genetic redundancy in C. elegans HSPGs more
restricted. C. elegans has two orthologues of glypicans, gpn-1
[27] and lon-2 [18] and a single orthologue of syndecan, sdn-1
[20], collagen XVIII, cle-1 [22] and perlecan, unc-52 [30].
Mutants in syndecan/sdn-1 display the strongest HSN migration
defect. A null allele of sdn-1, zh20, [26] and an in-frame deletion
allele ok449 display 52% and 53% HSN migration defects,
respectively (Fig. 1). Notably, 12% (zh20; 12 out of 111 neurons)
and 17% (ok449; 18 out of 109) of all the HSNs failed to migrate
at all in sdn-1 mutants (Fig. 1). In glypican/lon-2 (e678) mutants
all the HSNs undergo partial migration but 19% (31 out of 163)
fail to reach wild type position (Figure 1), whereas single mutants
in the other glypican, gpn-1 (ok377), have wild type HSN
migration. Collagen XVIII/cle-1 (cg120) mutants displayed 15%
defect in HSN migration (Fig. 1).
To test whether the different HSPGs have redundant functions
or whether each HSPG has its own role in HSN migration, HSPG
mutants were analyzed in combinations. Mutations in lon-2 (e678)
and cle-1 (cg120) enhanced HSN migration defects of sdn-1 (zh20)
from 52% (n= 111) to 77% (n= 77; P,0.001) and 65% (n= 81)
respectively (Fig. 2). Similar enhancement of HSN migration
defect was observed in combination with the sdn-1 ok449 allele.
The neuron migration defect was further enhanced to 82% (47 out
of 62 cells) in cle-1 lon-2 sdn-1 triple mutants (Fig. 2), suggesting
that CLE-1/collagen XVIII, LON-2/glypican and SDN-1/
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syndecan play independent roles in parallel neuron migration
pathways. Interestingly however, double mutants in lon-2 (e678)
and cle-1 (cg120) did not display significantly enhanced HSN
migration defect as compared to either single mutant alone (20%
HSN migration defect in cle-1 lon-2 double mutant; n = 117).
Mutations in gpn-1/glypican did not significantly enhance the
HSN migration defect of sdn-1 mutants (57%; n= 164). However,
gpn-1 (ok377) mutation further enhanced the defects seen in lon-2
sdn-1 double mutants from 77% to 84% in triple mutants.
Notably, there was a significant increase in the proportion of
neurons that failed to migrate at all in lon-2 sdn-1 gpn-1 triple
mutants as compared to lon-2 sdn-1 double mutants (33%
compared 9% of all neurons, respectively; P,0.001).
Role of heparan sulfate biosynthetic enzymes for HSN
migration
zh20 is a null allele of sdn-1/syndecan [26], whereas ok449 is
an in-frame deletion of the second and third exons [20]. This
deletion abolishes two of the three consensus heparan sulfate
attachment sites (Ser-Gly) of the SDN-1 protein. Truncated SDN-
1 protein is present in ok449 mutants, but it does not contain any
HS chains as detected by monoclonal antibodies against HS
(Figure S1 and Methods S1). zh20 and ok449 alleles exhibit
identical HSN migration defects, suggesting that the role of SDN-1
in HSN migration is predominantly mediated via the HS chains.
rib-1 and rib-2 are HS polymerases (EXT/EXTL orthologues)
required for the biosynthesis of HS chains [23,24,31]. Homozy-
gous mutations in rib-1 (ok556) are lethal or sterile [24] and
although some homozygous rib-2 (tm710) mutants from hetero-
zygous mothers become adults their progeny dies shortly after
gastrulation [31]. Homozygous rib-2 (tm710) mutants from
Figure 1. Multiple HSPGs are required for migration of hermaphrodite specific neurons (HSNs). (A) The HSNs visualized using ptph-
1::GFP expression (zdIs13) in wild type background, ventral view. Left and right HSNs are labeled. Left HSN (HSNL) is out of focal plane and is marked
with an asterisk. The position of the vulva is marked with a dashed line. The HSN cell bodies, which are positioned posterior to the vulval opening,
send axons along the left and right ventral nerve cord to the nerve ring in the pharynx. A branch of these axons innervates the vulval muscles. (B)
HSN migration defect in glypican/lon-2 (e678) mutant, lateral view. Arrows point to the HSN cell bodies which are both posteriorly misplaced. The
position of the vulva is marked with a dashed line. Anterior is to left and posterior is to right in both (A) and (B). (C) Schematic drawing shows ventral
view of the HSNs within the C. elegans body plan. The HSNs are born in the tail of the embryo and as the embryo begins to elongate the HSNs
migrate through the posterior part of the animal (dashed arrow). The position of HSNs in HSPG mutant background was scored as percentage of
neuron migration where 0% is no migration, 100% is wild type neuron position and .100% is over-migration (anterior to vulva). The position of the
bubble represents the position of the neurons. The size of the bubble indicates percentage of HSN cell bodies that have migrated to each position;
numbers indicate percentage/size of the bubble. All strains carry zdIs13. ncells; number of neurons analyzed for each strain.
doi:10.1371/journal.pone.0102919.g001
Figure 2. Multiple HSPGs are required in parallel guidance
pathways for neural migration. Double mutants in HSPG core
proteins display more severe neuron migration defects than single
mutants and the defects are enhanced in triple mutants. Note that
although mutations in gpn-1 (ok377) alone do not result in defects in
HSN migration, removing gpn-1 from sdn-1 lon-2 mutant results in
significantly more neurons failing to migrate at all. ncells; number of
HSNs analyzed for each strain.
doi:10.1371/journal.pone.0102919.g002
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heterozygous mothers were analyzed but were found to have no
defects in HSN migration (nanimals=50). The presence of maternal
rib-2 mRNA in the embryo at the time of HSN migration may
provide enough RIB-2 protein to mask any defects that result from
complete lack of RIB-2. hst-1 encodes an orthologue of ndst,
heparan N-de-acetylase-N-sulfotransferase. Deletion mutation in
ndst/hst-1 (ok1068) is also homozygous lethal preventing analysis
of homozygous offspring from homozygous mutant mothers.
Hence the focus on the study was on enzymes modifying HS
further in the biosynthetic pathway, mutants of which are all
viable. Single mutants in C. elegans heparan C5-epimerase, hse-5
(tm472), and heparan 2-O-sulfotransferases, hst-2 (ok595) have
15% and 30% defects in HSN migration, respectively, whereas
single mutants in heparan 6-O-sulfotransferase, hst-6 (ok273), are
wild type for HSN migration (Fig. 3 and [19,21,26]. C. elegans has
two orthologues of heparan 3-O-sulfotransferases, hst-3.1 and hst-
3.2. Single mutants in hst-3.1 (tm734) are wild type for HSN
migration, whereas hst-3.2 (tm3006) mutants have 17% defects in
HSN migration (Fig. 3).
Removal of HS 3- and 6-O-sulfation enhance HSN
migration defects in HS epimerase mutants
Although eliminating either HST-6 or HST-3.1 alone or in
combination as a double mutant of hst-3.1; hst-6 do not affect
HSN migration, both hst-3.1 (tm734) and hst-6 (ok273) signifi-
cantly enhance the defects in hse-5 epimerase mutants from 15%
to 47% and 36% respectively (Fig. 4; P,0.001). In contrast, hse-5
hst-2 double mutants are not more severely affected than hst-2
single mutants (28% compared to 30% HSN defect; Figs. 3 and
4A).
Heparan 2-O- and 6-O-sulfotransferase mutants have
additive defects in HSN migration
Genetic elimination of multiple O-sulfotransferases has very
robust effects on HSN migration in C. elegans. Removal of both
HS 6- and 2-O-sulfotransferases in hst-6 hst-2 double mutants
leads to 83% (n= 86) HSN migration defect compared to 30%
defect in hst-2 single mutants (Fig. 4B; P,0.001). In hst-2 single
mutants only 2% of the HSNs failed to migrate at all and
remained positioned in the tail. In contrast, in hst-6 hst-2 double
mutants 17% of all HSNs failed to initiate migration suggesting
that removing both HS 2- and 6-O-sulfation severely disrupts
molecular interactions required for neuron migration. Intriguingly,
further removal of one of the 3-O-sulfotransferases, HST-3.1,
from hst-6 hst-2 double mutants suppresses the HSN migration
defect (Fig. 4B). In hst-3.1; hst-6 hst-2 triple mutants 53%
(n= 176) of the HSNs are posteriorly misplaced, with only 2%
failing to migrate at all. Removal of HST-3.1 in the hst-3.1 hst-2
double mutant also weakly suppresses the HSN migration defects
of single hst-2 mutants to 21% (n= 83; P,0.05). However, genetic
elimination of the other 3-O-sulfotransferase, HST-3.2, from hst-2
mutant slightly increases the HSN migration defects to 35%
(n= 268) in the hst-3.2 hst-2 double mutant.
HS modification dependence on HSPG core protein
Specific HS modifications are critical for defined developmental
processes in vertebrates. For example, mice lacking heparan 2-O-
sulfation have total renal agenesis [11] suggesting that 2-O-sulfates
are critical for the growth factors acting in kidney development
[32]. HS 2-O-sulfates regulate growth factors involved in the
induction and differentiation of kidney mesoteric mesenchyme
[33], whereas 6-O-sulfates regulate growth factors required for
ureteric bud branching later in kidney development [34]. The
HSPGs carrying these HS modifications have not been identified.
Neither is it known if the same HSPG undergoes developmental
changes in its HS or whether different HSPGs carry the
Figure 3. Effects of genetic elimination of HS epimerase or HS
O-sulfotransferases on HSN migration. Mutations in hst-2, hse-5
and hst-3.2, lead to defects in HSN migration in otherwise wild type
genetic background. Mutants in hst-6 and hst-3.1 are wild type for HSN
migration.
doi:10.1371/journal.pone.0102919.g003
Figure 4. Combinatorial effects of eliminating HS epimerase
and O-sulfotransferases for neural migration. (A) Removal of HS
3- and 6-O-sulfotransferases enhances the defects in HS epimerase
mutants. C. elegans with genetic deletion in either hst-3.1 or hst-6 or in
combination of both have wild type HSN migration. However,
eliminating either hst-3.1 or hst-6 in hse-5 epimerase background
significantly enhances the neural phenotype. In contrast, eliminating
hst-2 in hse-5 background does not alter the combined phenotype as
compared to hst-2 mutants alone. (B) Genetic elimination of HS 2- and
6-O-sulfotransferases has strong additive effects on HSN migration.
Note the significant increase in neurons (17%) that fail to migrate at all
in hst-6 hst-2 double mutants. Genetic removal of hst-3.1 suppresses
HSN migration defects of hst-2 and hst-6 hst-2 double mutants.
doi:10.1371/journal.pone.0102919.g004
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structurally different HS chains. Gene knock-out of a HS
biosynthetic enzyme such as HS2ST is anticipated to affect all
HSPG core proteins.
To gain insight into relationship between HSPG protein cores
and specific HS modifications, effects of eliminating HS biosyn-
thetic enzymes in different core protein mutant backgrounds were
tested. Eliminating 3- or 6-O-sulfates using hst-3.2 (tm3006) or
hst-6 deletion alleles in sdn-1 null background did not alter the
severity of the HSN phenotype (53% and 52% defect, respectively)
as compared to sdn-1 null mutants alone. In contrast, genetic
removal of 2-O-sulfates in the sdn-1 null background (sdn-1 hst-2
double mutant) lead to 87% (n= 119) failure of HSN migration to
wild type position, with 37% of HSNs failing to migrate at all
(Fig. 5). Similarly, double mutants of hse-5 epimerase and sdn-1
display more severe defects with 61% of HSNs (n = 81) failing to
migrate to wild type position and 33% failing to migrate at all
(compared with 17% in sdn-1 single mutants; P,0.01). In
contrast, additional removal of 2-O-sulfates from glypican/lon-2
and collagen XVIII/cle-1 mutant backgrounds did not signifi-
cantly alter the neuron defects observed in a single mutant. In lon-
2 hst-2 double mutants 37% (n= 91) and in cle-1; hst-2 double
mutants 24% of all neurons (n = 129) failed to migrate to wild type
position. The pattern of migration defects was not significantly
changed either.
Tissue specific expression of HS biosynthetic enzymes
and HSPGs
Reporter constructs were used to assess expression patterns of
hst-3.1 and hst-3.2 and revealed complementary expression
patterns for the two 3-O-sulfotransferases. hst-3.2 reporter is
expressed predominantly in neurons (Fig. 5C) whereas hst-3.1
reporter is expressed predominantly in pharyngeal and body wall
muscle (Fig. 5D). Similar complementary expression patterns have
previously been shown for the other HS biosynthetic enzymes and
HSPGs. hst-6 is predominantly expressed by neurons, hst-2 is
expressed in the muscle and hypodermis, and hse-5 is expressed in
the hypodermis [19,21]. sdn-1 is predominantly expressed in
neurons (Fig. 5B; [26], whereas lon-2 and cle-1 are expressed in
muscle and hypodermis [18,22].
Heparan sulfates are required for HSN migration and
axon guidance but not process outgrowth
Deletion mutations in genes encoding for HSPG core proteins
and for HS biosynthetic enzyme, led to defects in HSN migration
and axon guidance. However, process outgrowth per se was not
affected in any of the mutants (Fig. 6). In other words, irrespective
of whether the HSN cell body had migrated to wild type or
aberrant position or failed to migrate at all, the HSNs extended
axonal projections, suggesting that the process of axon outgrowth
is independent of HS/HSPGs (Fig. 6). The defects in HSN
migration and axon guidance were also independent of each other.
HSN cell bodies which had failed to migrate at all often extended
axons that appeared projecting correctly (Fig. 6A). Conversely,
HSN cell bodies which had migrated to correctly to the vulval
proximity frequently projected aberrant axons which failed to
reach their appropriate targets. HS/HSPGs thus play independent
roles in HSN neuron migration and in axon guidance.
Discussion
Multiple HSPGs were found to play a role in the migration of
the HSNs. Glypican/LON-2, collagen XVIII/CLE-1 and synde-
can/SDN-1 are required in parallel neuron guidance pathways as
genetic elimination of two or all of the HSPGs increases the
severity of the HSN migration phenotype. In the absence of all
three HSPGs only 20% of HSNs migrate normally. Although
mutations in the gpn-1/glypican alone do not lead to defects in
HSN migration, genetic elimination of gpn-1 in lon-2 sdn-1
background significantly increased the proportion of neurons that
failed to migrate at all suggesting that in the absence of LON-2,
GPN-1 plays a redundant role resulting in increased severity of
defects when both glypicans are genetically eliminated.
sdn-1 is expressed by predominantly in neurons including the
HSNs [26], whereas lon-2 and cle-1 are expressed in the
hypodermis and body wall muscle [18,22]. This suggests that
SDN-1/syndecan is required in the migrating neuron, the HSNs,
whereas LON-2/glypican and CLE-1/collagen XVIII are re-
quired in the matrix that supports HSN migration and all three
HSPGs act in concert. When LON-2/glypican is present, GPN-1/
glypican is not required for HSN migration. Moreover, SDN-1 HS
chains are important for HSN migration as sdn-1 null allele and
‘HS-less’ allele display identical phenotypes.
Simultaneous genetic removal of both hst-2 and hst-6 results in
almost complete loss of HSN migration suggesting that heparan
O-sulfation is needed for HSN migration. Biochemical HS
disaccharide analysis has shown increased N-sulfation in hst-2
hst-6 double mutants [35], however, as suggested by this study,
glucosamine N-sulfation is not able to functionally compensate for
the lack of O-sulfation. Genetic removal of hst-6 and hst-3.1 in
Figure 5. SDN-1 and HS 2-O-sulfate regulate parallel neuron
migration pathways. (A) Removing heparan 2-O-sulfation in sdn-1
mutants significantly enhances HSN migration defects. Note the
increased proportion (39%) of HSNs that fail to migrate at all in sdn-1
hst-2 double mutants. Genetic elimination of hst-6 or hst-3.2 in sdn-1
mutant background does not change the HSN migration phenotype.
(B–D) Expression profiles of sdn-1, hst-3.2 and hst-3.1 reporter genes. (B)
sdn-1 reporter is expressed predominantly in the nervous system,
including neurons of the nerve ring (arrow) and in the ventral (VNC;
arrowheads) and dorsal nerve cords. (C) hst-3.2 reporter is also
expressed in neurons as seen in some neurons in the nerve ring in
the pharynx (arrows) and in the tail ganglia and along ventral nerve
cord axon tracks (arrowheads). (D) hst-3.1 reporter is expressed in the
muscle; both the pharyngeal muscle (arrow) and body wall muscle
express hst-3.1 reporter. Scale bars B, D; 50 mm, C; 20 mm.
doi:10.1371/journal.pone.0102919.g005
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hse-5 epimerase mutant background significantly enhances defects
in HSN migration whereas removal of hst-2 in hse-5 background
does not. Biochemical HS disaccharide analysis has shown
compensatory 6-O-sulfation in hse-5; hst-2 double mutants
retaining higher total 2- and 6-O-sulfation per 100 disaccharides
than that seen in hse-5; hst-2 double mutants [35]. Heparan 2-O-
sulfation occurs predominantly in IdoA residues that have
undergone C5-epimerisation (by HSE-5 epimerase) from GluA
although some 2-O-sulfation occurs also on GluA residues. It is
also plausible that removing both HSE-5 and HST-2 affects the
same sugar units in HS, whereas removing HSE-5 and HST-6 or
HST-3.1 affects both hexuronic acid and glucosamine units of HS.
Hexuronic acids have very flexible conformation, and 2-O-
sulfation further increases this flexibility [36]. Changes to this
flexibility may affect HS-ligand interactions. In contrast, 3- and 6-
O-sulfate groups do not affect conformation of HS to the extent
that 2-O-sulfates do [37], which could partly explain why
eliminating either HST-3.1 or HST-6, or both, does not affect
HSN migration in vivo provided other HS modifications are
present. Biochemical HS analysis has shown that hst-6 mutants
have increased compensatory 2-O-sulfation, retaining the com-
bined 2- and 6-O-sulfation per 100 disaccharides at wild type
levels [35], which may explain why single mutants of hst-6 display
wild type neuron migration phenotype.
3-O-sulfation is the rarest of HS modifications, occurring in less
than 5% of HS derived disaccharides. Findings that elimination of
hst-3.1 suppress the HSN migration defects in hst-2 single and hst-
2 hst-6 double mutant backgrounds suggest that in the absence of
2-O-sulfates or 2- and 6-O-sulfates the presence of 3-O-sulfates is
unfavorable for the biological function of the HS. Alternatively, in
the absence of 2-O- or 2- and 6-O-sulfation, 3-O-sulfation may be
up-regulated. NMR studies have shown that 3-O-sulfates can in
some cases influence the conformation of the uronic acid adjacent
to the 3-O-sulfated glucosamine [38]. Up-regulation of 3-O-
sulfation could thus change the overall HS saccharide conforma-
tion and alter ligand binding properties.
Compensatory mechanism in HS biosynthesis has been
demonstrated in vertebrates. The classical view of HS biosynthesis
is that N-deacetylation/N-sulfation of glucosamine residues
precedes other HS modifications that occur primarily in previously
N-sulfated domains. However, some 6-O-sulfation is observed in
mouse embryonic stem cells deficient of NDST1 and NDST2 and
which completely lack N-sulfation [39]. The compensatory
modifications that occur when one or more HS modification
enzymes are eliminated together with the conformational changes
to the resulting HS may alter ligand binding properties leading to
altered phenotypic outcomes.
sdn-1 hst-2 double mutants exhibit HSN migration defect that
resembles combined elimination of CLE-1, SDN-1 and LON-2
HSPGs. Similarly, genetic elimination of HS 2- and 6-O-sulfation
resembles loss of SDN-1 and HST-2, or combined loss of CLE-1,
SDN-1 and LON-2 HSPGs. hst-6 sdn-1 double mutants appear
like sdn-1 single mutants. Genetic elimination of hst-3.2, leads to
weak defects in HSN migration, but sdn-1 hst-3.2 double mutants
mirror sdn-1 single mutants. hst-6 and hst-3.2 are predominantly
expressed by neurons whereas hst-2 and hst-3.1 are expressed in
the muscle and hypodermis. Combining the normal expression
patterns of these genes and the HSN phenotypes observed in the
mutants, suggest a model in which SDN-1, which is expressed in
the migrating neuron, contains HS chains decorated with 3- and
6-O-sulfates, and the SDN-1 HS chains are important for normal
HSN migration. Removal of HST-2 from LON-2 or CLE-1
mutants, did not alter HSN migration defect of the single mutants,
suggesting that LON-2/glypican and CLE-1/collagen XVIII,
present in the matrix that supports migrating neurons, contain 2-
O-sulfated HS required for normal HSN migration. Removal of
both HS 2- and 6-O-sulfotransferases resembles loss of all three
HSPGs, suggesting that the role of all these HSPGs in neuron
migration is predominantly mediated by the HS chains. Based on
these findings, it is also plausible that in C. elegans, tissue specific
expression of different HSPGs and HS O-sulfotransferases in part
determines core protein specificity of HS modifications.
In conclusion, a neural development model in C. elegans was
used to address relationship between different HSPG core proteins
and distinct HS modifications for biological function in vivo.
Genetic analysis demonstrated that SDN-1/syndecan, LON-2/
glypican and CLE-1/collagen XVIII are required in parallel
guidance pathways and genetic elimination of all three HSPGs
results in almost complete failure of neural migration. The
different HSPG core proteins require distinct HS modifications
to mediate in vivo functions. The core protein is thus not a carrier
of HS chains with any or random modifications. In C. elegans this
core protein-HS specificity may in part be imposed by tissue
specific expression of the genes encoding for HSPGs and HS
biosynthetic enzymes. This is the first demonstration of relation-
ship between HS modifications and distinct HSPG core proteins in
a defined biological process and provides a novel insight into the
biological functions of HS and HSPGs. Proteoglycan core protein
specificity should be considered when interpreting data or
considering therapies relating to distinct HS structures.
Figure 6. HS and HSPGs are required for axon guidance but not
for process outgrowth. All HSNs analysed extended axon projections
irrespective of the position of the neural cell body. However, axon
guidance was defective in mutants lacking HS biosynthetic enzymes or
HSPGs. (A) 17% of all HSNs in sdn-1 (ok449) mutants failed to migrate at
all and remain in the tail as the right HSN (HSNR) shown here. The HSN
extends axon projection along the ventral nerve cord (arrowheads). In
this animal, the left HSN (HSNL) is in wild type position. (B) In some
mutants, the HSN cell bodies have migrated to wild type position, but
project axons aberrantly. In this hst-3.2 (tm3006) hst-2 (ok595) double
mutant, a branch of the HSN axon projects posteriorly (arrowheads). (C)
In some mutants, the HSN axons project posteriorly (arrowheads) and
completely fail to follow their stereotyped pathway. (A to C); Dashed
line indicates the position of vulva. Anterior is to the left, posterior to
the right, ventral down in all panels. Scale bars 50 mm.
doi:10.1371/journal.pone.0102919.g006
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Supporting Information
Figure S1 Biochemical analysis of sdn-1mutants. SDN-1
is absent in both zh20 (null allele) and ok449 (in-frame deletion
abolishing HS attachment sites) mutants as detected by monoclo-
nal antibodies recognising the HS ‘‘stub’’ as a result of treatment
with heparinase III. Proteins were purified using anion-exchange
chromatography (DEAE), which enriches for negatively charged
HSPGs. SDN-1 core protein is however present in ok449 mutants
as detected by anti-SDN-1 antibodies following immunoprecipi-
tation using anti-SDN-1 antibodies.
(TIF)
Methods S1 HSPG purification and Western blotting.
Mixed stage C. elegans were lysed and proteins purified essentially
as described [40] with the following modifications. Total protein
lysates were either passed through DEAE anion-exchange matrix
(GE Healthcare Life Sciences) and after washing the matrix with
0.25 M NaCl, bound proteins were eluted with 1.5 M NaCl.
Alternatively, SDN-1 was immuno-precipitated with rabbit
polyclonal anti-SDN-1 antibodies made against synthetic peptide
corresponding to the entire cytoplasmic domain of SDN-1. DEAE
purified proteins were treated with heparitinase III (Ibex, Canada)
as described [27]. Proteins were separated on 10% SDS-PAGE
and blotted to Immobilon-P membranes (Millipore, USA).
Heparitinase III treated samples were detected with monoclonal
anti-HS stub antibody 3G10 (Seikagaku, Japan) followed by anti-
mouse HRP secondary antibody (GE Healthcare) and immuno-
precipitated samples were detected with anti-SDN-1 antibody
followed by anti-rabbit HRP conjugated secondary antibody (GE
Healthcare). Western blots were visualised using ECL Chemilu-
menescence detection kit (Biological Industries, Beit Haemek,
Israel).
(PDF)
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